Noscapine HCl

Dapagliflozin Propanediol

Noscapine Base

Opium Tincture

 keyboard_arrow_right keyboard_arrow_left
spot_img

About Us

Parand Darou Pharmaceutical Co.
Parand Darou is one of Iran’s leading knowledge-based pharmaceutical companies, focused on sustainable development, technological innovation, and international market expansion.
Established in 2006, the company specializes in the production of narcotic pharmaceutical products and is recognized as the second private company in Iran officially licensed by the Food and Drug Administration to manufacture these products.
In recent years, Parand Darou has achieved significant growth through exporting pharmaceutical products to international markets, expanding its presence in China, Russia, Chile, Kenya, India, El Salvador, Iraq, and Nigeria, obtaining GMP certification for its advanced production lines, developing API (Active Pharmaceutical Ingredient) production capabilities, and expanding its pharmaceutical product portfolio.
With a commitment to professional ethics, innovation, quality improvement, social responsibility, and environmental protection, Parand Darou aims to contribute to public health and improve quality of life.
DISCOVER MORE

Active Pharmaceutical Ingredient (API)

PAPAVER TO PHARMACEUTICAL

spot_img

Pharmaceutical Intermediates

Papaverine Base

Papaverine Base is an opium-derived alkaloid and one of the most critical pharmaceutical intermediates manufactured by Parand Darou Co. It possesses potent antispasmodic properties and serves primarily as a key precursor in the synthesis of pharmaceutical products intended for the treatment of visceral and vascular spasms. Clinical Applications By acting directly...

Noscapine Base

Noscapine Base is a prominent natural poppy alkaloid and a key pharmaceutical intermediate manufactured by Parand Darou Co. It serves as a vital precursor in the synthesis of Noscapine Hydrochloride and various antitussive pharmaceutical formulations. Pharmacological Significance Unlike other opium derivatives, Noscapine is non-narcotic, non-sedating, and non-addictive. It exerts its antitussive...

Morphine Base

Morphine Base is the primary natural opioid alkaloid and one of the most strategic pharmaceutical intermediates manufactured by Parand Darou Co. It serves as a vital raw material and key precursor in the synthesis of various pharmaceutical salts, including Morphine Sulfate, Morphine Hydrochloride, and other semi-synthetic opioid analgesics and...

Noroxymorphone

Noroxymorphone is a strategic, semi-synthetic opioid intermediate manufactured by Parand Darou Co. This compound serves as a critical precursor and the fundamental building block in the synthesis of life-saving opioid antagonists, including Naloxone and Naltrexone, as well as the potent analgesic derivative Nalbuphine. Pharmacological Significance Characterized by a hydroxyl group at...
Parand Darou - Interactive Product Portfolio
💊

Parand Darou Manufacturing Complex

Comprehensive API, Advanced Intermediate & Finished Dosage Forms Portfolio

Product Explorer
Showing 42 Products

Codeine phosphate hemihydrate

API
CAS Number 41444-62-6
Pharmacopoeia USP, BP
analgesic, pain management Details

Methadone Hydrochloride

API
CAS Number 1095-90-5
Pharmacopoeia USP, BP
Addiction therapy Details

Oxycodone Hydrochloride

API
CAS Number 124-90-3
Pharmacopoeia USP, BP
Pain management Details

Morphine Sulfate

API
CAS Number 6211-15-0
Pharmacopoeia USP, BP
Pain management Details

Buprenorphine Hydrochloride

API
CAS Number 53152-21-9
Pharmacopoeia BP, USP, IP
addiction therapy Details

Naltrexone Hydrochloride

API
CAS Number 850808-02-5
Pharmacopoeia BP, USP
Addiction therapy Details

Tramadol Hydrochloride

API
CAS Number 36282-47-0
Pharmacopoeia USP, BP
Pain management Details

Naloxone Hydrochloride

API
CAS Number 51481-60-8
Pharmacopoeia BP, USP
Opioid overdose antidote Details

Oxymorphone Hydrochloride

API
CAS Number 357-07-3
Pharmacopoeia USP
pain management Details

Morphine Hydrochloride

API
CAS Number 60 55-06-7
Pharmacopoeia EP, BP
pain management Details

Dihydrocodeine Tartrate

API
CAS Number 5965-13-9
Pharmacopoeia USP,BP
Pain management Details

Hydrocodone Bitartrate

API
CAS Number 34195-34-1
Pharmacopoeia BP, USP
Pain management Details

Dihydrocodeine Phosphate

API
CAS Number 24204-13-5
Pharmacopoeia JP
pain management Details

Opium Tincture 1% bulk

API
CAS Number 8029-99-0
Pharmacopoeia USP
opiate Agonist & antiperistatic agent(addiction therapy, Diarrhea treament) Details

Fentanyl Citrate

API
CAS Number 990-73-8
Pharmacopoeia USP
. Non-opioid pain management Details

Remifentanil Hydrochloride

API
CAS Number 132539-07-2
Pharmacopoeia BP
short term anaesthetic and analgesic Details

Sufentanil Citrate

API
CAS Number 60561-17-3
Pharmacopoeia USP
non-opioid pain management Details

Noscapine Hydrochloride

API
CAS Number 912-60-7
Pharmacopoeia EP,BP, JP
Antitussive Details

Papaverine Hydrochloride

API
CAS Number 61-25-6
Pharmacopoeia USP, BP
antispasmodic Details

Empagliflozin

API
CAS Number 864070-44-0
Pharmacopoeia In house
Antidiabetic type 2 Details

Sitagliptin Phosphate

API
CAS Number 654671-77-9
Pharmacopoeia USP, BP
Antidiabetic type 2 Details

Dapagliflozin Propanediol

API
CAS Number 960404-48-2
Pharmacopoeia USP
Antidiabetic type 2 Details

Rivaroxaban

API
CAS Number 366789-02-8
Pharmacopoeia BP
anticoagulant Details

Pantoprazole Sodium

API
CAS Number 164579-32-2
Pharmacopoeia BP, USP
Proton pump inhibitor Details

Omeprazole

API
CAS Number 73590-58-6
Pharmacopoeia BP, USP
Proton pump inhibitor Details

Lansoprazole

API
CAS Number 103577-45-3
Pharmacopoeia BP
Proton pump inhibitor Details

Noscapine Crude

Intermediate
CAS Number 128-62-1
Pharmacopoeia In house
Antitussive Details

Noscapine

API
CAS Number 128-62-1
Pharmacopoeia USP, BP, JP
Antitussive Details

Noroxymorphone

Intermediate
CAS Number 33522-95-1
Pharmacopoeia In house
Naloxone and naltrexone precursor Details

Papaverine Crude

Intermediate
CAS Number 58-74-2
Pharmacopoeia In house
Antispasmodic Details

Morphine

Intermediate
CAS Number 57-27-2
Pharmacopoeia In house
Pain management Details

Codeine anhydrous

Intermediate
CAS Number 76-57-3
Pharmacopoeia USP
Pain management Details

Codeine Monohydrate

Intermediate
CAS Number 6059-47-8
Pharmacopoeia USP, BP
Pain management Details

OXYCODONE Tablet

Finished FDF
CAS Number Finished Formulation (N/A)
Pharmacopoeia Finished Product Specification
Opioid Analgesic/ Severe pain management Details

ACETAMINOPHEN/OXYCODONE Tablet (PAXADONE)

Finished FDF
CAS Number Finished Formulation (N/A)
Pharmacopoeia Finished Product Specification
Opioid Analgesic/ severe pain management Details

IBUPROFEN/OXYCODONE Tablet (BRUDON)

Finished FDF
CAS Number Finished Formulation (N/A)
Pharmacopoeia Finished Product Specification
Strong Opioid Analgesic (severe pain) Details

BUPRENORPHINE TABLET

Finished FDF
CAS Number Finished Formulation (N/A)
Pharmacopoeia Finished Product Specification
Opioid use disorder( Acute chronic pain management) Details

TRAMADOL TABLET

Finished FDF
CAS Number Finished Formulation (N/A)
Pharmacopoeia Finished Product Specification
Opioid Agonist (Moderate to severe chronic pain management) Details

METHADONE TABLET

Finished FDF
CAS Number Finished Formulation (N/A)
Pharmacopoeia Finished Product Specification
Addiction treatment Details

NOSCAPINE SYRUP (pd NOSCA)

Finished FDF
CAS Number Finished Formulation (N/A)
Pharmacopoeia Finished Product Specification
Dry cough suppressant Details

METHADONE SYRUP

Finished FDF
CAS Number Finished Formulation (N/A)
Pharmacopoeia Finished Product Specification
- Details

OPIUM TINCTURE

Finished FDF
CAS Number Finished Formulation (N/A)
Pharmacopoeia Finished Product Specification
opiate Agonist & antiperistatic agent(addiction therapy, Diarrhea treament) Details

Product Name

API Pharmacopoeia: USP
Pharmacopoeia & Regulatory Standards
Pharmacopoeia Standard
-
Grade / Quality
-
CAS Number (Exact)
-
Chemical Identification & Molecular Structure
Molecular Formula
-
Molecular Weight (g/mol)
-
IUPAC / Chemical Name
-
Physical & Technical Specifications
Therapeutic Class & Application
Primary Function
-
Therapeutic Category
-
Industrial Sector
-
Overview: -

Parand Darou News

Parand Darou CEO Highlights Pharmaceutical Industry Resilience, API Development and Export Growth at Pharmex 2026

Parand Darou News
Milan, Italy – Pharmex 2026 During Pharmex 2026, Mr. Yahya Mirzaei, CEO of Parand Darou Pharmaceutical Company, discussed the importance...

Parand Darou Shines on the Global Stage: Awarded National Exemplary Exporter and Golden Statue for the Second Time

Parand Darou News
Parand Darou Awarded "National Exemplary Exporter" Title for the Second Time According to the Public Relations department of Parand Darou...

Dr. Yahya Mirzaei Appointed as New CEO of Parand Darou

Parand Darou News
Dr. Yahya Mirzaei Appointed as the New CEO of Parand Darou In an official appointment, Mr. Behzad Mohammadi, CEO of...

Parand Darou Honored as National Exemplary Exporter of 2024 by the President and Minister of Industry, Mine and Trade

Parand Darou News
Parand Darou Named National Exemplary Exporter of 2024: A Milestone in Pharmaceutical Innovation On Sunday, October 20, 2024, coinciding with...

Finished Dosage Forms (FDFs)

Noscapine Syrup

FDF
Noscapine Syrup, marketed under the brand name pd NOSCA, is a specialized Finished Dosage Form (FDF) manufactured by Parand Darou Co. Containing 7 mg of Noscapine per 5 ml, this product is a potent non-narcotic antitussive. It acts centrally on the cough center in the medulla oblongata to effectively...
Read more

Methadone Syrup

FDF
Methadone Syrup is a key Finished Dosage Form (FDF) manufactured by Parand Darou Co. Formulated with a concentration of 25 mg per 5 ml (equivalent to 5 mg/ml), this product serves as a long-acting synthetic opioid agonist. It is extensively utilized in clinical protocols for Medication-Assisted Treatment (MAT) and...
Read more

Oxycodone FC Tablet

FDF
Oxycodone FC Tablet is a premium Finished Dosage Form (FDF) and a potent pure opioid agonist manufactured by Parand Darou Co. Engineered for clinical efficacy, Oxycodone acts primarily on central μ-opioid receptors to deliver robust analgesic relief. It is indicated for the management and relief of moderate-to-severe pain, particularly...
Read more

Pharma News

Olive Oil and Blood Pressure: Three Potential Pathways Supporting Heart Health

Pharma News
Olive Oil and Blood Pressure: Three Potential Pathways Supporting Heart Health Extra virgin olive oil, due to its high content...

Regeneron’s Experimental Drug Combination May Help Preserve Muscle Mass During Weight Loss Treatment

Pharma News
Regeneron's Experimental Drug Combination May Help Preserve Muscle Mass During Weight Loss Treatment According to new data scheduled to be...